Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07507435 · ClinicalTrials.gov registry record · NA
Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults
A NA study, sponsored by Seattle Institute for Biomedical and Clinical Research.
- Not yet
- Registry status
- NA
- Development phase
- 480
- Enrollment target
NCT07507435 is a NA study that has not yet begun recruiting, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 480 participants.
The verdict
NCT07507435, a NA study, has not yet begun recruiting, sponsored by Seattle Institute for Biomedical and Clinical Research.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
Study Summary
People with HIV (PWH) continue to experience elevated risk of community-acquired pneumonia despite effective antiretroviral therapy. Pneumonia contributes to hospitalization, respiratory failure, cardiovascular complications, long-term decline in lung function, and mortality. Several modifiable factors increase this risk, including active smoking, inadequate receipt of respiratory vaccinations, and inappropriate or prolonged use of inhaled corticosteroids (ICS) or proton-pump inhibitors (PPIs). OPTIMIZE Lung-HIV is a multicenter, patient-level randomized controlled hybrid Type 1 effectiveness-implementation trial evaluating whether a proactive, pharmacist-led E-consult intervention can improve evidence-based pulmonary pharmacotherapy for PWH. Pharmacists will review electronic health records, generate tailored recommendations, and pre-enter orders related to smoking cessation pharmacotherapy, vaccinations, and deprescribing of ICS or PPIs. Providers may enact or modify recommendations as clinically appropriate. The trial will assess the proportion of recommendations enacted within 3 months (primary outcome) and at 12 months (maintenance) and will use mixed methods guided by CFIR and RE-AIM to evaluate adoption, feasibility, acceptability, and implementation barriers and facilitators.
Interventions
- OTHER E-consult
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2026-08 |
| Est. Completion | 2029-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07507435
The ClinicalTrials.gov registry entry for NCT07507435 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Institute for Biomedical and Clinical Research, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which E-consult is the first listed.
NCT07507435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07507435 about?
NCT07507435 is a clinical study titled "Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults". People with HIV (PWH) continue to experience elevated risk of community-acquired pneumonia despite effective antiretroviral therapy. Pneumonia contributes to hospitalization, respiratory failure, cardiovascular complications, long-term decline in lung function, and mortality. Several modifiable fact...
What is the current status of trial NCT07507435?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2026-08. Estimated completion is 2029-09.
What interventions are being tested in trial NCT07507435?
The interventions under investigation include: E-consult (OTHER).
Who is sponsoring clinical trial NCT07507435?
This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.